Find information on thousands of medical conditions and prescription drugs.

Hyperbilirubinemia

Jaundice, also known as icterus (adjective:"Icteric"), is yellowing of the skin, sclera (the white of the eyes) and mucous membranes caused by increased levels of bilirubin in the human body. Usually the concentration of bilirubin in the blood must exceed 2–3mg/dL for the coloration to be easily visible. Jaundice comes from the French word jaune, meaning yellow. more...

Home
Diseases
A
B
C
D
E
F
G
H
Hairy cell leukemia
Hallermann Streiff syndrome
Hallux valgus
Hantavirosis
Hantavirus pulmonary...
HARD syndrome
Harlequin type ichthyosis
Harpaxophobia
Hartnup disease
Hashimoto's thyroiditis
Hearing impairment
Hearing loss
Heart block
Heavy metal poisoning
Heliophobia
HELLP syndrome
Helminthiasis
Hemangioendothelioma
Hemangioma
Hemangiopericytoma
Hemifacial microsomia
Hemiplegia
Hemoglobinopathy
Hemoglobinuria
Hemolytic-uremic syndrome
Hemophilia A
Hemophobia
Hemorrhagic fever
Hemothorax
Hepatic encephalopathy
Hepatitis
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatoblastoma
Hepatocellular carcinoma
Hepatorenal syndrome
Hereditary amyloidosis
Hereditary angioedema
Hereditary ataxia
Hereditary ceroid...
Hereditary coproporphyria
Hereditary elliptocytosis
Hereditary fructose...
Hereditary hemochromatosis
Hereditary hemorrhagic...
Hereditary...
Hereditary spastic...
Hereditary spherocytosis
Hermansky-Pudlak syndrome
Hermaphroditism
Herpangina
Herpes zoster
Herpes zoster oticus
Herpetophobia
Heterophobia
Hiccups
Hidradenitis suppurativa
HIDS
Hip dysplasia
Hirschsprung's disease
Histoplasmosis
Hodgkin lymphoma
Hodgkin's disease
Hodophobia
Holocarboxylase...
Holoprosencephaly
Homocystinuria
Horner's syndrome
Horseshoe kidney
Howell-Evans syndrome
Human parvovirus B19...
Hunter syndrome
Huntington's disease
Hurler syndrome
Hutchinson Gilford...
Hutchinson-Gilford syndrome
Hydatidiform mole
Hydatidosis
Hydranencephaly
Hydrocephalus
Hydronephrosis
Hydrophobia
Hydrops fetalis
Hymenolepiasis
Hyperaldosteronism
Hyperammonemia
Hyperandrogenism
Hyperbilirubinemia
Hypercalcemia
Hypercholesterolemia
Hyperchylomicronemia
Hypereosinophilic syndrome
Hyperhidrosis
Hyperimmunoglobinemia D...
Hyperkalemia
Hyperkalemic periodic...
Hyperlipoproteinemia
Hyperlipoproteinemia type I
Hyperlipoproteinemia type II
Hyperlipoproteinemia type...
Hyperlipoproteinemia type IV
Hyperlipoproteinemia type V
Hyperlysinemia
Hyperparathyroidism
Hyperprolactinemia
Hyperreflexia
Hypertension
Hypertensive retinopathy
Hyperthermia
Hyperthyroidism
Hypertrophic cardiomyopathy
Hypoaldosteronism
Hypocalcemia
Hypochondrogenesis
Hypochondroplasia
Hypoglycemia
Hypogonadism
Hypokalemia
Hypokalemic periodic...
Hypoparathyroidism
Hypophosphatasia
Hypopituitarism
Hypoplastic left heart...
Hypoprothrombinemia
Hypothalamic dysfunction
Hypothermia
Hypothyroidism
Hypoxia
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Causes of jaundice

When red blood cells die, the heme in their hemoglobin is converted to bilirubin in the spleen and in the kupffer cells in the liver. The bilirubin is processed by the liver, enters bile and is eventually excreted through feaces.

Consequently, there are three different classes of causes for jaundice. Pre-hepatic or hemolytic causes, where too many red blood cells are broken down, hepatic causes where the processing of bilirubin in the liver does not function correctly, and post-hepatic or extrahepatic causes, where the removal of bile is disturbed.

Pre-hepatic

Pre-hepatic (or hemolytic) jaundice is caused by anything which causes an increased rate of hemolysis (breakdown of red blood cells). In tropical countries, malaria can cause jaundice in this manner. Certain genetic diseases, such as glucose 6-phosphate dehydrogenase deficiency can lead to increase red cell lysis and therefore hemolytic jaundice. Defects in bilirubin metabolism also present as jaundice. Jaundice usually comes with high fevers.

Hepatic

Hepatic causes include acute hepatitis, hepatotoxicity and alcoholic liver disease. Less common causes include primary biliary cirrhosis, Gilbert's syndrome and metastatic carcinoma. Jaundice commonly seen in the newborn baby is another example of hepatic jaundice.

Post-hepatic

Post-hepatic (or obstructive) jaundice, also called cholestasis, is caused by an interruption to the drainage of bile in the biliary system. The most common causes are gallstones in the common bile duct and pancreatic cancer in the head of the pancreas. Other causes include strictures of the common bile duct, ductal carcinoma, pancreatitis and pancreatic pseudocysts. A rare cause of obstructive jaundice is Mirizzi's syndrome.

The presence of pale stools suggests an obstructive or post-hepatic cause as normal feces get their colour from bile pigments.

Neonatal jaundice

Neonatal jaundice is usually harmless: this condition is often seen in infants around the second day after birth, lasting till day 8 in normal births, or to around day 14 in premature births. Serum bilirubin normally drops to a low level without any intervention required: the jaundice is presumably a consequence of metabolic and physiological adjustments after birth. Infants with neonatal jaundice are often treated with bili lights, exposing them to high levels of colored light to break down the bilirubin. This works due to a photo oxidation process occurring on the bilirubin in the subcutaneous tissues of the neonate. Light energy creates isomerization of the bilirubin and consequently transformation into compounds that the new born can excrete via urine and stools. Blue light is typically used for this purpose. Green light is more effective at breaking down bilirubin, but is not commonly used because it makes the babies appear sickly, which is disturbing to observers.

Read more at Wikipedia.org


[List your site here Free!]


AAP issues guidelines on hyperbilirubinemia in healthy, term newborns - American Academy of Pediatrics
From American Family Physician, 1/1/95

The American Academy of Pediatrics (AAP) has developed guidelines to aid in the evaluation and treatment of the healthy, term infant with hyperbilirubinemia. The guidelines include recommendations on evaluation and management according to the infant's age (in hours). A discussion of phototherapy is in the appendix. According to the AAP, the guidelines attempt to describe a range of acceptable practices, recognizing that adequate data are not available to provide more precise recommendations. The following information has been excerpted from the recommendations, which were published in the October 1994 issue of Pediatrics.

Every year, approximately 60 percent of the 4 million infants born in the United States become clinically jaundiced. These infants receive various forms of evaluation and treatment. According to the AAP, there are no simple solutions to the management of jaundiced neonates. It is not known at what bilirubin concentration or under what circumstances significant risk of brain damage occurs or when the risk of damage exceeds the risk of treatment. Uncertainties about the relationship between serum bilirubin levels and brain damage as well as differences in patient populations and practice settings contribute to variations in the management of hyperbilirubinemia.

Some conditions increase the risk of hyperbilirubinemia, including history of a sibling with hyperbilimbinemia, decreasing gestational age, breast feeding and a large weight loss after birth. Although newborns at 37 weeks of gestation and over are considered "term," infants at 37 to 38 weeks of gestation may not nurse as well as more mature infants, and there is a strong correlation between decreasing gestational age and risk for hyperbilirubinemia. Infants born at 37 weeks' gestation are much more likely to develop a serum bilirubin level of 13 mg per dL (222 [mu]mol per L) or higher than are those born at 40 weeks' gestation.

The AAP believes that breast feeding in healthy, term newborns should not be interrupted and that continued and frequent breast feeding (at least eight to 10 times every 24 hours) should be encouraged. Supplementing feedings with water or dextrose water does not lower the bilirubin level in jaundiced, healthy, breast-feeding infants. A variety of options are possible, including supplementation of breast-feeding with formula or the temporary interruption of breast-feeding and substitution with formula, either of which can be accompanied by phototherapy.

The evaluation and treatment of hyperbilirubinemia is presented in the table and in the clinical algorithm on the following pages.

COPYRIGHT 1995 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group

Return to Hyperbilirubinemia
Home Contact Resources Exchange Links ebay